Atea Pharmaceuticals Ratios (2020-2022) | AVIR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022
Profitability
EBT Margin					46.55%	14.47%	-67.34%	63.08%
EBIT Margin					46.46%	14.38%	-67.50%	63.06%
EBITDA Margin					46.46%	14.38%	-85.93%	60.95%
Operating Margin					46.46%	14.38%	-67.50%	63.06%
Net Margin					46.55%	2.55%	-85.93%	60.95%
FCF Margin					-25.52%	-28.73%	68.89%	-39.25%
Efficiency
Assets Average				486.87M	852.14M	856.10M	857.52M	808.20M	745.04M	705.76M	690.46M
Equity Average		-58.25M	-69.82M	235.65M	567.03M	592.06M	589.66M	645.76M	694.98M	670.17M	661.82M
Invested Capital	-53.37M	-63.13M	-76.51M	547.80M	586.26M	597.86M	581.45M	710.08M	679.88M	660.46M	663.19M
Asset Utilization Ratio								0.43
Leverage & Solvency
Equity Ratio			-0.69	0.63	0.70	0.69	0.69	0.92	0.95	0.95	0.97
Valuation
Enterprise Value	-17.15M	-115.79M	-105.38M	2,601.62M	4,275.25M	960.73M	104.39M	-21.44M	-217.66M	-93.35M	-191.23M	400.61M
Market Capitalization				3,451.74M	5,109.01M	1,777.19M	944.05M	742.94M	487.89M	591.13M	473.74M	400.61M
Return Ratios
Return on Sales								0.34%
Return on Capital Employed					0.05%	0.07%	0.06%	0.18%	0.09%	0.04%	0.05%
Return on Invested Capital										0.01%	0.04%
Return on Assets					0.03%	0.04%	0.03%	0.15%	0.06%	0.02%	0.05%
Return on Equity					0.05%	0.06%	0.04%	0.19%	0.07%	0.02%	0.05%